US2010094010A1PendingUtilityA1
Chemical process
Est. expiryFeb 20, 2024(expired)· nominal 20-yr term from priority
A61P 9/12A61P 5/00A61P 9/00A61P 35/00A61P 25/04A61P 13/12C07D 401/14C07F 5/025C07D 413/14Y02P20/55C07F 5/02
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Processes for preparing compounds of Formula I and IV are described.
Claims
exact text as granted — not AI-modified1 . A process for the preparation of a compound of the Formula I
wherein,
X 1 is selected from O, NR 1 or S; and
X 2 is selected from CH or N;
wherein R 1 is a nitrogen-protecting group,
which comprises:—
the sequential reaction of a compound of the Formula II
with,
(i) methyl- or an optionally substituted aryl-lithium; and then (ii) n-butyl-, s-butyl-, t-butyl- or n-hexyl-lithium; and then (iii) a borate ester.
2 . The process according to claim 1 wherein X 1 is O.
3 . The process according to claim 1 wherein X 2 is N.
4 . The process according to claim 1 wherein said methyl- or an optionally substituted aryl-lithium is 4-methylphenyllithium or methyllithium.
5 . The process according to of claim 1 wherein said n-butyl-, s-butyl-, t-butyl- or n-hexyl-lithium is n-hexyllithium or n-butyllithium.
6 . The process according to claim 1 wherein said borate ester is triisopropylborate.
7 . [4-(1,3,4-Oxadiazol-2-yl)phenyl]boronic acid prepared by the process as claimed in claim 1 .
8 . A process for preparing compounds of Formula IV:
which comprises coupling [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid with a compound of Formula III:
wherein P is a nitrogen-protecting group.
9 . The process according to claim 8 which takes place in the presence of
(i) a source of palladium (0) selected from PdCl 2 , Pd(Ph 3 P) 4 or Pd(OAc) 2 ; (ii) a suitable ligand selected from triphenylphosphine or 3,3′,3″-phosphinidyne tris(benzenesulphonic acid) trisodium salt; (iii) a base selected from triethylamine, benzyldimethylamine, N-methylmorpholine, N-methylpiperidine, triethanolamine, ethyldiethanolamine, diisopropylethylamine, potassium acetate, cesium fluoride or potassium fluoride.
10 . The process according to claim 8 wherein said [4-(1,3,4-oxadiazol-2-yl)phenyl]boronic acid is prepared according to the process as claimed in of claim 1 .
11 . The process according to claim 8 wherein P is isobutoxycarbonyl.
12 . A compound of Formula IV:
wherein P is a nitrogen-protecting group.
13 . A compound of Formula IV as claimed in claim 11 which is N -(isobutoxycarbonyl) N -(3-methoxy-5-methylpyrazin-2-yl)-2-(4-[1,3,4-oxadiazol-2-yl]phenyl)pyridine-3-sulphonamide.Join the waitlist — get patent alerts
Track US2010094010A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.